Filter by: patients
What is Botulinum Toxin Type A?

Botulinum Toxin Type A is a neuromuscular blocker age. It is used to treat various types of dystonia (neurological movement disorders); for blepharospasm and strabismus; for primary axillary hyperhidrosis (excessive perspiration); and it is also used for cosmetic purposes.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Stiffness/Spasticity 31 11 Efficacy_major Efficacy_moderate Efficacy_slight
Other 25 6 Efficacy_major Efficacy_moderate Efficacy_slight
Excess saliva 20 7 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none
Bladder problems 12 6 Efficacy_major Efficacy_none
Migraine headaches 12 2 Efficacy_major Efficacy_none
Dystonia 8 4 Efficacy_moderate Efficacy_slight Efficacy_none

See all 129 patients currently taking Botulinum Toxin Type A

Mouse over the table for more information

Reported Dosages

Frequently reported dosages based on patients currently taking Botulinum Toxin Type A. See all 54 dosages

  100units as needed IU as needed 2 100units as needed as needed 1 app every 3 months 100 units yearly 100 units every 3 months 200 units every 3 months 100 units monthly 100 units one time
  16 Number of Patients: 16 5 Number of Patients: 5 5 Number of Patients: 5 4 Number of Patients: 4 3 Number of Patients: 3 5 Number of Patients: 5 16 Number of Patients: 16 13 Number of Patients: 13 5 Number of Patients: 5 3 Number of Patients: 3  

Reported Stop Reasons

Why Patients Stopped Taking Botulinum Toxin Type A (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 22   Did not seem to work: 34%
Course of treatment ended 17   Course of treatment ended: 27%
Other 13   Other: 20%
Not indicated 10   Not indicated: 16%
Side effects too severe 9   Side effects too severe: 14%
Expense 8   Expense: 13%
Personal research 4   Personal research: 6%
Doctor's advice 3   Doctor's advice: 5%

See all 63 patients who’ve stopped taking Botulinum Toxin Type A

Currently Taking Botulinum Toxin Type A

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Stopped Taking Botulinum Toxin Type A

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Botulinum Toxin Type A

Always
42 65%
Usually
8 12%
Sometimes
7 11%
Never
8 12%

Burden

Difficulty being on treatment

Burden of Botulinum Toxin Type A

Very
8 12%
Somewhat
9 14%
A little
17 26%
Not at all
31 48%

Cost

Paid out of pocket

Cost of Botulinum Toxin Type A

$200+
12 29%
$100-199
8 19%
$50-99
3 7%
$25-49
0 0%
< $25
19 45%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 25, 2012.